Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Researchers uncover new mechanism of how Ebola viruses escape immune system

A research team from Tübingen and Göttingen has described in the renowned journal Cell Reports a new mechanism how the Ebola virus escapes the immune system.

12 Feb 2019

Call for a global alert on Ebola in Democratic Republic of Congo

The Lancet has reported about the alarming status of Ebola in the Democratic Republic of Congo (DRC) on the 4th of this month following a reported 785 deaths due to the disease in the country.

6 Feb 2019

New online software package trains health care workers in safe Ebola disease response

In a world where we can travel the globe by jet, diseases that were once thought to plague faraway places can now strike close to home.

4 Feb 2019

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

28 Jan 2019

Scientists are working to develop a new way to detect Zika virus

A collaboration of scientists including Professor Jean Patterson, Ph.D., of Texas Biomedical Research Institute, is working on a new way to detect Zika virus that will help guide clinicians in their treatment of patients with the disease.

28 Jan 2019

Investigational Ebola treatment found to be safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.

25 Jan 2019

Ebola virus identified in a West African bat

The government of Liberia, in partnership with the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and EcoHealth Alliance, announced the discovery of Ebola virus in a bat in Liberia.

24 Jan 2019

Scientists solve another piece of Ebola virus puzzle

A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

17 Jan 2019

Scientists develop monoclonal antibodies combinations that protect animals from Ebola viruses

Scientists from academia, industry, and government have developed a combination of monoclonal antibodies that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe.

11 Jan 2019

Experimental drug can protect against Ebola in a single dose

There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are now available in Cell Host & Microbe.

9 Jan 2019

USC research could lay foundation for a vaccine against tick-borne virus

Two groundbreaking discoveries by USC researchers could lead to medications and a vaccine to treat or prevent a hemorrhagic fever transmitted by a new tick species before it spreads across the United States.

7 Jan 2019

Scientists identify new bat-borne virus related to Ebola

Researchers from Singapore's Duke-NUS Medical School, in collaboration with scientists in China, have identified and characterized a new genus of filovirus from a Rousettus bat in China. Their findings were published in the journal Nature Microbiology.

7 Jan 2019

"Miracle" baby survives Ebola in Congo and rapid a new Ebola detection device

A female baby was diagnosed with the deadly Ebola when she was only six days old. According to the health officials in the Democratic Republic of the Congo (DRC), she seemed to have miraculously recovered from the viral infection.

17 Dec 2018

Study finds drug targets for Ebola, Dengue, and Zika viruses

No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes and UC San Francisco may finally change that. Scientists identified key ways the three viruses hijack the body's cells, and they found at least one potential drug that can disrupt this process in human cells.

13 Dec 2018

Researchers discover Ebola-fighting protein in human cells

Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new Northwestern Medicine study.

13 Dec 2018

FDA announces emergency use authorization of Ebola fingerstick test with portable reader

Today, the U.S. Food and Drug Administration announced that an emergency use authorization has been issued for a rapid, single-use test for the detection of Ebola virus.

12 Nov 2018

At-risk healthcare workers being vaccinated against Ebola in Uganda

Healthcare workers in Uganda have begun vaccinating high risk health workers against the deadly viral infection Ebola this week. This is the first time that a vaccination drive has begun before the actual outbreak.

7 Nov 2018

Research reveals high stability of hepatitis B viruses

At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

30 Oct 2018

Scientists obtain clearest ever image of Ebola virus protein

For the first time, researchers have managed to image the structure of a central component of the Ebola virus.

17 Oct 2018

Researchers develop two-pronged approach for targeting Ebola virus

In a new study researchers have developed a two-pronged approach for targeting Ebola virus infection using linked nucleic acid (LNA) antisense oligonucleotides (ASOs)designed to interfere both genes essential for translation of Ebola virus genes and to block production of an intracellular human protein needed for the virus to enter cells.

12 Oct 2018